RIVAROXABAN REDUCES SPONTANEOUS AND LARGE MYOCARDIAL INFARCTIONS: FINDINGS FROM THE ATLAS ACS 2 – TIMI 51 TRIAL

RIVAROXABAN REDUCES SPONTANEOUS AND LARGE MYOCARDIAL INFARCTIONS: FINDINGS FROM THE ATLAS ACS 2 – TIMI 51 TRIAL

Background Rivaroxaban reduces cardiovascular death, myocardial infarction (MI), or stroke in patients following acute coronary syndrome (ACS).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E3-E3
Hauptverfasser: Cavender, Matthew, Braunwald, Eugene, Gibson, C. Michael, Wiviott, Stephen, Murphy, Sabina, Amuchastegui, Marcos, Ophuis, Anton Oude, van Hessen, Maarten, Mega, Jessica
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Rivaroxaban reduces cardiovascular death, myocardial infarction (MI), or stroke in patients following acute coronary syndrome (ACS).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)60004-2